This inventor holds 1 USPTO granted patent. Top assignee: The Ohio State University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations in Liver Cancer Treatment by Satheesh Ellipilli
Introduction
Satheesh Ellipilli is an innovative inventor based in Columbus, OH (US). He has made significant contributions to the field of cancer treatment, particularly focusing on liver cancer. His work involves the development of advanced RNA nanoparticle technology aimed at improving therapeutic outcomes for patients.
Latest Patents
Satheesh Ellipilli holds 1 patent for his groundbreaking invention titled "RNA nanoparticle for liver cancer treatment." This patent discloses compositions and methods for the targeted treatment of liver cancers using Paclitaxel and miR-122. The composition comprises an RNA nanostructure conjugated to a hepatocyte targeting ligand, paclitaxel, and miR-122, which facilitates intracellular drug delivery specifically to liver cancer cells. The RNA nanoparticle is designed to involve three or more self-assembled synthetic RNA oligonucleotides that form a central core domain, with at least three double-stranded arms extending away from the core.
Career Highlights
Satheesh Ellipilli is affiliated with The Ohio State University, where he continues to advance his research in cancer treatment. His work is characterized by a strong focus on innovative solutions that leverage nanotechnology for medical applications.
Collaborations
He has collaborated with notable researchers in the field, including Peixuan Guo and Hongzhi Wang. These collaborations have further enriched his research and contributed to the development of effective cancer therapies.
Conclusion
Satheesh Ellipilli's contributions to liver cancer treatment through his innovative RNA nanoparticle technology represent a significant advancement in the field. His work exemplifies the potential of targeted therapies in improving patient outcomes.